{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/4.1-1603.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/4.1-1603.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/4.1-1603.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/4.1-1603.html"}],"law_id":63491,"edition_id":1,"section_id":63491,"structure_id":14131,"section_number":"4.1-1603","catch_line":"Dispensing cannabis products; report","history":"2023, cc. 740, 744, 760, 773, 780, 794; 2024, c. 732.","full_text":"A\n\nA pharmaceutical processor or cannabis dispensing facility shall dispense or deliver cannabis products only in person to (i) a patient who is a Virginia resident or temporarily resides in Virginia and has been issued a valid written certification; (ii) such patient’s registered agent; or (iii) if such patient is a minor or a vulnerable adult as defined in § 18.2-369, such patient’s parent or legal guardian who is a Virginia resident or temporarily resides in Virginia. A companion may accompany a patient into a pharmaceutical processor’s dispensing area or cannabis dispensing facility. Prior to the initial dispensing of cannabis products pursuant to each written certification, a pharmacist or pharmacy technician employed by the pharmaceutical processor or cannabis dispensing facility shall make and maintain, on site or remotely by electronic means, for two years a paper or electronic copy of the written certification that provides an exact image of the document that is clearly legible; shall view, in person or by audiovisual means, a current photo identification of the patient, registered agent, parent, or legal guardian; and shall verify current board registration of the corresponding registered agent if applicable. Thereafter, an initial dispensing may be delivered to the patient, registered agent, parent, legal guardian, or designated caregiver facility. Prior to any subsequent dispensing of cannabis products pursuant to each written certification, an employee or delivery agent shall view a current photo identification of the patient, registered agent, parent, or legal guardian and the current board registration issued to the registered agent if applicable. No pharmaceutical processor or cannabis dispensing facility shall dispense more than a 90-day supply, as determined by the dispensing pharmacist or certifying practitioner, for any patient during any 90-day period. A pharmaceutical processor or cannabis dispensing facility may dispense less than a 90-day supply of a cannabis product for any patient during any 90-day period; however, a pharmaceutical processor or cannabis dispensing facility may dispense more than one cannabis product to a patient at one time. No more than four ounces of botanical cannabis shall be dispensed for each 30-day period for which botanical cannabis is dispensed. In determining the appropriate amount of a cannabis product to be dispensed to a patient, a pharmaceutical processor or cannabis dispensing facility shall consider all cannabis products dispensed to the patient and adjust the amount dispensed accordingly.B\n\nA pharmaceutical processor or cannabis dispensing facility shall dispense only cannabis products produced on the premises of a pharmaceutical processor permitted by the Board or cannabis products that have been formulated with extracts from industrial hemp acquired by a pharmaceutical processor from a registered industrial hemp handler or processor pursuant to § 4.1-1602. A pharmaceutical processor may begin cultivation upon being issued a permit by the Board.C\n\nThe Board shall report annually by December 1 to the Chairmen of the House Committee on General Laws and the Senate Committee on Rehabilitation and Social Services on the operation of pharmaceutical processors and cannabis dispensing facilities issued a permit by the Board.D\n\nThe concentration of total tetrahydrocannabinol in any cannabis product on site may be up to 15 percent greater than or less than the level of total tetrahydrocannabinol listed in the approved cannabis product registration. A pharmaceutical processor and cannabis dispensing facility shall ensure that such concentration in any cannabis product on site is within such range. A pharmaceutical processor producing cannabis products shall establish a stability testing schedule of cannabis products that have an expiration date of longer than 12 months.","order_by":null,"text":{"0":{"id":231302,"text":"A pharmaceutical processor or cannabis dispensing facility shall dispense or deliver cannabis products only in person to (i) a patient who is a Virginia resident or temporarily resides in Virginia and has been issued a valid written certification; (ii) such patient’s registered agent; or (iii) if such patient is a minor or a vulnerable adult as defined in § 18.2-369, such patient’s parent or legal guardian who is a Virginia resident or temporarily resides in Virginia. A companion may accompany a patient into a pharmaceutical processor’s dispensing area or cannabis dispensing facility. Prior to the initial dispensing of cannabis products pursuant to each written certification, a pharmacist or pharmacy technician employed by the pharmaceutical processor or cannabis dispensing facility shall make and maintain, on site or remotely by electronic means, for two years a paper or electronic copy of the written certification that provides an exact image of the document that is clearly legible; shall view, in person or by audiovisual means, a current photo identification of the patient, registered agent, parent, or legal guardian; and shall verify current board registration of the corresponding registered agent if applicable. Thereafter, an initial dispensing may be delivered to the patient, registered agent, parent, legal guardian, or designated caregiver facility. Prior to any subsequent dispensing of cannabis products pursuant to each written certification, an employee or delivery agent shall view a current photo identification of the patient, registered agent, parent, or legal guardian and the current board registration issued to the registered agent if applicable. No pharmaceutical processor or cannabis dispensing facility shall dispense more than a 90-day supply, as determined by the dispensing pharmacist or certifying practitioner, for any patient during any 90-day period. A pharmaceutical processor or cannabis dispensing facility may dispense less than a 90-day supply of a cannabis product for any patient during any 90-day period; however, a pharmaceutical processor or cannabis dispensing facility may dispense more than one cannabis product to a patient at one time. No more than four ounces of botanical cannabis shall be dispensed for each 30-day period for which botanical cannabis is dispensed. In determining the appropriate amount of a cannabis product to be dispensed to a patient, a pharmaceutical processor or cannabis dispensing facility shall consider all cannabis products dispensed to the patient and adjust the amount dispensed accordingly.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":231303,"text":"A pharmaceutical processor or cannabis dispensing facility shall dispense only cannabis products produced on the premises of a pharmaceutical processor permitted by the Board or cannabis products that have been formulated with extracts from industrial hemp acquired by a pharmaceutical processor from a registered industrial hemp handler or processor pursuant to § 4.1-1602. A pharmaceutical processor may begin cultivation upon being issued a permit by the Board.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A","next_prefix":"C"},"2":{"id":231304,"text":"The Board shall report annually by December 1 to the Chairmen of the House Committee on General Laws and the Senate Committee on Rehabilitation and Social Services on the operation of pharmaceutical processors and cannabis dispensing facilities issued a permit by the Board.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B","next_prefix":"D"},"3":{"id":231305,"text":"The concentration of total tetrahydrocannabinol in any cannabis product on site may be up to 15 percent greater than or less than the level of total tetrahydrocannabinol listed in the approved cannabis product registration. A pharmaceutical processor and cannabis dispensing facility shall ensure that such concentration in any cannabis product on site is within such range. A pharmaceutical processor producing cannabis products shall establish a stability testing schedule of cannabis products that have an expiration date of longer than 12 months.","type":"section","prefixes":["D"],"prefix":"D","entire_prefix":"D","prefix_anchor":"D","level":1,"prior_prefix":"C"}},"ancestry":[{"id":14131,"edition_id":1,"name":"Medical Cannabis Program","identifier":"16","label":"chapter","depth":3,"order_by":1,"parent_id":13297,"metadata":{},"date_created":"2026-06-26 03:46:58","date_modified":"2026-06-26 03:46:58","permalink":{"id":219541,"object_type":"structure","relational_id":14131,"identifier":"16","token":"4.1\/II\/16","url":"\/4.1\/II\/16\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13297,"edition_id":1,"name":"Cannabis Control Act","identifier":"II","label":"subtitle","depth":2,"order_by":1,"parent_id":13129,"metadata":{},"date_created":"2026-06-26 03:44:35","date_modified":"2026-06-26 03:44:35","permalink":{"id":219415,"object_type":"structure","relational_id":13297,"identifier":"II","token":"4.1\/II","url":"\/4.1\/II\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13129,"edition_id":1,"name":"Alcoholic Beverage and Cannabis Control","identifier":"4.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:44:19","date_modified":"2026-06-26 03:44:19","permalink":{"id":218569,"object_type":"structure","relational_id":13129,"identifier":"4.1","token":"4.1","url":"\/4.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":58467,"structure_id":14131,"section_number":"4.1-1600","catch_line":"Definitions","url":"\/4.1-1600\/","token":"4.1\/II\/16\/4.1-1600","metadata":false},{"id":63911,"structure_id":14131,"section_number":"4.1-1601","catch_line":"Certification for use of cannabis for treatment","url":"\/4.1-1601\/","token":"4.1\/II\/16\/4.1-1601","metadata":false},{"id":64137,"structure_id":14131,"section_number":"4.1-1602","catch_line":"Permit to operate pharmaceutical processor or cannabis dispensing facility","url":"\/4.1-1602\/","token":"4.1\/II\/16\/4.1-1602","metadata":false},{"id":63491,"structure_id":14131,"section_number":"4.1-1603","catch_line":"Dispensing cannabis products; report","url":"\/4.1-1603\/","token":"4.1\/II\/16\/4.1-1603","metadata":false},{"id":80608,"structure_id":14131,"section_number":"4.1-1603.1","catch_line":"Packaging and labeling; corrections; records","url":"\/4.1-1603.1\/","token":"4.1\/II\/16\/4.1-1603.1","metadata":false},{"id":56049,"structure_id":14131,"section_number":"4.1-1603.2","catch_line":"Cannabis product registration; approval, deviation, and modification","url":"\/4.1-1603.2\/","token":"4.1\/II\/16\/4.1-1603.2","metadata":false},{"id":60948,"structure_id":14131,"section_number":"4.1-1603.3","catch_line":"Advertising and marketing","url":"\/4.1-1603.3\/","token":"4.1\/II\/16\/4.1-1603.3","metadata":false},{"id":55273,"structure_id":14131,"section_number":"4.1-1604","catch_line":"Criminal liability; exceptions","url":"\/4.1-1604\/","token":"4.1\/II\/16\/4.1-1604","metadata":false},{"id":78315,"structure_id":14131,"section_number":"4.1-1605","catch_line":"Summary suspensions and restrictions","url":"\/4.1-1605\/","token":"4.1\/II\/16\/4.1-1605","metadata":false},{"id":65086,"structure_id":14131,"section_number":"4.1-1606","catch_line":"Confidentiality of reports, information, and records; penalty","url":"\/4.1-1606\/","token":"4.1\/II\/16\/4.1-1606","metadata":false}],"previous_section":{"id":64137,"structure_id":14131,"section_number":"4.1-1602","catch_line":"Permit to operate pharmaceutical processor or cannabis dispensing facility","url":"\/4.1-1602\/","token":"4.1\/II\/16\/4.1-1602","metadata":false},"next_section":{"id":80608,"structure_id":14131,"section_number":"4.1-1603.1","catch_line":"Packaging and labeling; corrections; records","url":"\/4.1-1603.1\/","token":"4.1\/II\/16\/4.1-1603.1","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/4.1-1603\/","history_text":"

This law was first created in 2023. The record of its establishment is cataloged in chapters 740<\/a>, 744<\/a>, 760<\/a>, 773<\/a>, 780<\/a>, and 794<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. It has been modified 1 time. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. That modification is as follows: in 2024, chapter 732<\/a>.<\/p>","references":false,"refers_to":[{"id":70553,"section_number":"18.2-369","catch_line":"Abuse and neglect of vulnerable adults; penalties","order_by":null,"url":"\/18.2-369\/"},{"id":64137,"section_number":"4.1-1602","catch_line":"Permit to operate pharmaceutical processor or cannabis dispensing facility","order_by":null,"url":"\/4.1-1602\/"}],"permalink":{"id":219555,"object_type":"law","relational_id":63491,"identifier":"4.1-1603","token":"4.1\/II\/16\/4.1-1603","url":"\/4.1-1603\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/4.1-1603\/","token":"4.1\/II\/16\/4.1-1603","dublin_core":{"Title":"Dispensing cannabis products; report","Type":"Text","Format":"text\/html","Identifier":"\u00a7 4.1-1603","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> A pharmaceutical processor<\/span> or cannabis dispensing facility<\/span> shall dispense<\/span> or deliver cannabis products<\/span> only in person to (i) a patient who is a Virginia resident or temporarily resides in Virginia and has been issued a valid written certification; (ii) such patient’s registered agent<\/span>; or (iii) if such patient is a minor<\/span> or a vulnerable adult as defined in § 18.2-369<\/a>, such patient’s parent or legal guardian who is a Virginia resident or temporarily resides in Virginia. A companion may accompany a patient into a pharmaceutical processor<\/span>’s dispensing area or cannabis dispensing facility<\/span>. Prior to the initial dispensing of cannabis products<\/span> pursuant to each written certification, a pharmacist<\/span> or pharmacy technician<\/span> employed by the pharmaceutical processor<\/span> or cannabis dispensing facility<\/span> shall make and maintain, on site or remotely by electronic means, for two years a paper or electronic copy of the written certification that provides an exact image of the document that is clearly legible; shall view, in person or by audiovisual means, a current photo identification of the patient, registered agent<\/span>, parent, or legal guardian; and shall verify current board<\/span> registration of the corresponding registered agent<\/span> if applicable. Thereafter, an initial dispensing may be delivered to the patient, registered agent<\/span>, parent, legal guardian, or designated caregiver facility<\/span>. Prior to any subsequent dispensing of cannabis products<\/span> pursuant to each written certification, an employee or delivery agent shall view a current photo identification of the patient, registered agent<\/span>, parent, or legal guardian and the current board<\/span> registration issued to the registered agent<\/span> if applicable. No pharmaceutical processor<\/span> or cannabis dispensing facility<\/span> shall dispense<\/span> more than a 90-day supply, as determined by the dispensing pharmacist<\/span> or certifying practitioner<\/span>, for any patient during any 90-day period. A pharmaceutical processor<\/span> or cannabis dispensing facility<\/span> may dispense<\/span> less than a 90-day supply of a cannabis product<\/span> for any patient during any 90-day period; however, a pharmaceutical processor<\/span> or cannabis dispensing facility<\/span> may dispense<\/span> more than one cannabis product<\/span> to a patient at one time. No more than four ounces of botanical cannabis<\/span> shall be dispensed for each 30-day period for which botanical cannabis<\/span> is dispensed. In determining the appropriate amount of a cannabis product<\/span> to be dispensed to a patient, a pharmaceutical processor<\/span> or cannabis dispensing facility<\/span> shall consider all cannabis products<\/span> dispensed to the patient and adjust the amount dispensed accordingly. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> A pharmaceutical processor<\/span> or cannabis dispensing facility<\/span> shall dispense<\/span> only cannabis products<\/span> produced on the premises of a pharmaceutical processor<\/span> permitted by the Board<\/span> or cannabis products<\/span> that have been formulated with extracts from industrial hemp acquired by a pharmaceutical processor<\/span> from a registered industrial hemp handler or processor pursuant to § 4.1-1602<\/a>. A pharmaceutical processor<\/span> may begin cultivation<\/span> upon being issued a permit by the Board<\/span>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

C.<\/span> The Board<\/span> shall report annually by December 1 to the Chairmen of the House Committee on General Laws<\/span> and the Senate Committee on Rehabilitation and Social Services on the operation of pharmaceutical processors<\/span> and cannabis dispensing facilities issued a permit by the Board<\/span>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

D.<\/span> The concentration of total tetrahydrocannabinol<\/span> in any cannabis product<\/span> on site may be up to 15 percent greater than or less than the level of total tetrahydrocannabinol<\/span> listed in the approved cannabis product<\/span> registration. A pharmaceutical processor<\/span> and cannabis dispensing facility<\/span> shall ensure that such concentration in any cannabis product<\/span> on site is within such range. A pharmaceutical processor<\/span> producing cannabis products<\/span> shall establish a stability testing<\/span> schedule of cannabis products<\/span> that have an expiration date of longer than 12 months. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nDISPENSING CANNABIS PRODUCTS; REPORT (\u00a7 4.1-1603)\n\nA. A pharmaceutical processor or cannabis dispensing facility shall dispense or\ndeliver cannabis products only in person to (i) a patient who is a Virginia\nresident or temporarily resides in Virginia and has been issued a valid written\ncertification; (ii) such patient’s registered agent; or (iii) if such\npatient is a minor or a vulnerable adult as defined in § 18.2-369, such\npatient’s parent or legal guardian who is a Virginia resident or\ntemporarily resides in Virginia. A companion may accompany a patient into a\npharmaceutical processor’s dispensing area or cannabis dispensing\nfacility. Prior to the initial dispensing of cannabis products pursuant to each\nwritten certification, a pharmacist or pharmacy technician employed by the\npharmaceutical processor or cannabis dispensing facility shall make and\nmaintain, on site or remotely by electronic means, for two years a paper or\nelectronic copy of the written certification that provides an exact image of the\ndocument that is clearly legible; shall view, in person or by audiovisual means,\na current photo identification of the patient, registered agent, parent, or\nlegal guardian; and shall verify current board registration of the corresponding\nregistered agent if applicable. Thereafter, an initial dispensing may be\ndelivered to the patient, registered agent, parent, legal guardian, or\ndesignated caregiver facility. Prior to any subsequent dispensing of cannabis\nproducts pursuant to each written certification, an employee or delivery agent\nshall view a current photo identification of the patient, registered agent,\nparent, or legal guardian and the current board registration issued to the\nregistered agent if applicable. No pharmaceutical processor or cannabis\ndispensing facility shall dispense more than a 90-day supply, as determined by\nthe dispensing pharmacist or certifying practitioner, for any patient during any\n90-day period. A pharmaceutical processor or cannabis dispensing facility may\ndispense less than a 90-day supply of a cannabis product for any patient during\nany 90-day period; however, a pharmaceutical processor or cannabis dispensing\nfacility may dispense more than one cannabis product to a patient at one time.\nNo more than four ounces of botanical cannabis shall be dispensed for each\n30-day period for which botanical cannabis is dispensed. In determining the\nappropriate amount of a cannabis product to be dispensed to a patient, a\npharmaceutical processor or cannabis dispensing facility shall consider all\ncannabis products dispensed to the patient and adjust the amount dispensed\naccordingly.\n\nB. A pharmaceutical processor or cannabis dispensing facility shall dispense\nonly cannabis products produced on the premises of a pharmaceutical processor\npermitted by the Board or cannabis products that have been formulated with\nextracts from industrial hemp acquired by a pharmaceutical processor from a\nregistered industrial hemp handler or processor pursuant to § 4.1-1602. A\npharmaceutical processor may begin cultivation upon being issued a permit by the\nBoard.\n\nC. The Board shall report annually by December 1 to the Chairmen of the House\nCommittee on General Laws and the Senate Committee on Rehabilitation and Social\nServices on the operation of pharmaceutical processors and cannabis dispensing\nfacilities issued a permit by the Board.\n\nD. The concentration of total tetrahydrocannabinol in any cannabis product on\nsite may be up to 15 percent greater than or less than the level of total\ntetrahydrocannabinol listed in the approved cannabis product registration. A\npharmaceutical processor and cannabis dispensing facility shall ensure that such\nconcentration in any cannabis product on site is within such range. A\npharmaceutical processor producing cannabis products shall establish a stability\ntesting schedule of cannabis products that have an expiration date of longer\nthan 12 months.\n\nHISTORY: 2023, cc. 740, 744, 760, 773, 780, 794; 2024, c. 732.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}